In memoriam: Sampath Parthasarathy
Sampath Parthasarathy, a lipid scientist and cardiovascular researcher at the University of Central Florida, died of pneumonia on Dec. 1, 2020, the American Society for Biochemistry and Molecular Biology learned recently. He was 73.

Born Dec. 27, 1947, in India, Parthasarathy earned his Ph.D. at the Indian Institute of Science in Bangalore and was a postdoctoral fellow at Kyoto University in Japan, Duke University and the University of Minneapolis. He held positions at the University of California, San Diego, Emory University, Louisiana State University and Ohio State University before joining the faculty of the University of Central Florida College of Medicine in 2011, where he held an endowed chair in cardiovascular sciences and served as the associate dean for research. He was also is an inventor and held an MBA in technology management.
A recognized expert in lipids, Parthasarathy was credited with the co-discovery, while at UCSD, that oxidized low-density lipoprotein is involved in the initiation and progression of atherosclerosis. The paper on this finding is one of the most cited in atherosclerosis research. He also studied the beneficial effects of exercise and dietary polyunsaturated fats such as sesame oil. He researched both pro- and antioxidants in the context of multiple inflammatory diseases, including diabetes, endometriosis, Alzheimer’s and Crohn’s, “always approaching scientific challenges from novel (outside-the-box) perspectives, connecting the dots, and finding parallels that were inconspicuous to others,” according to a remembrance in the journal Arteriosclerosis, Thrombosis and Vascular Biology.
In addition to being an ASBMB member, Parthsarathy was involved with the American Heart Association, the South Asian Society for Atherosclerosis and Thrombosis and other societies. He served as editor-in-chief of the journal Healthcare, as co-editor-in-chief of the Journal of Medicinal Food, and on the editorial boards of numerous other journals, including the Journal of Lipid Research. Fondly known as “Dr. Sam,” he mentored more than 300 students, postdocs, clinical residents and junior investigators from around the world.
Parthsarathy was preceded in death by his first wife, Kalyani. He is survived by his wife, Linda; sons, Raghuveer and Bharath Parthasarathy, and their wives; and five grandchildren.
Enjoy reading ASBMB Today?
Become a member to receive the print edition four times a year and the digital edition monthly.
Learn moreGet the latest from ASBMB Today
Enter your email address, and we’ll send you a weekly email with recent articles, interviews and more.
Latest in People
People highlights or most popular articles

Hope for a cure hangs on research
Amid drastic proposed cuts to biomedical research, rare disease families like Hailey Adkisson’s fight for survival and hope. Without funding, science can’t “catch up” to help the patients who need it most.

Before we’ve lost what we can’t rebuild: Hope for prion disease
Sonia Vallabh and Eric Minikel, a husband-and-wife team racing to cure prion disease, helped develop ION717, an antisense oligonucleotide treatment now in clinical trials. Their mission is personal — and just getting started.

ASBMB members recognized as Allen investigators
Ileana Cristea, Sarah Cohen, Itay Budin and Christopher Obara are among 14 researchers selected as Allen Distinguished Investigators by the Paul G. Allen Family Foundation.

AI can be an asset, ASBMB educators say
Pedagogy experts share how they use artificial intelligence to save time, increase accessibility and prepare students for a changing world.

ASBMB undergraduate education programs foster tomorrow’s scientific minds
Learn how the society empowers educators and the next generation of scientists through community as well as accreditation and professional development programs that support evidence-based teaching and inclusive pedagogy.

Honors for Gagna and Sundquist
Claude Gagna is being honored for the diagnostic tool he developed that uses AI to streamline diagnostics. Wesley Sundquist is being honored for his role in finding that HIV’s capsid was a target for treatment.